World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
37096
World Ranking
5833
National Ranking
3132

Johannes Czernin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Johannes Czernin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 584 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Johannes Czernin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Johannes Czernin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Johannes Czernin is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in subfields such as Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, and Immunology.

The scientist's main topics of work emphasize Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Medical Imaging Techniques and Applications, Cancer, Lipids, and Metabolism, Peptidase Inhibition and Analysis, and Radiomics and Machine Learning in Medical Imaging.

Johannes Czernin has contributed to numerous publications. Notable recent papers include:

  • E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection, 2021, JAMA Oncology
  • Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study, 2021, The Lancet Oncology
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study, 2020, Journal of Nuclear Medicine
  • Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study, 2021, Journal of Nuclear Medicine

The scientist frequently publishes in venues including:

  • Journal of Nuclear Medicine
  • Journal of Clinical Oncology
  • European Journal of Nuclear Medicine and Molecular Imaging
  • European Urology
  • International Journal of Radiation Oncology*Biology*Physics

Collaboration is a notable aspect of their research, with frequent coauthors being:

  • Jérémie Calais
  • Wesley R. Armstrong
  • Wolfgang P. Fendler
  • Matthias Eiber
  • Ken Herrmann

Johannes Czernin's work spans a wide range of topics mostly centered on cancer and imaging techniques applied to diagnosis and treatment. Their publication record and partnerships indicate active engagement in advanced nuclear medicine, especially concerning prostate cancer and radiopharmaceutical development.

Best Publications

  • A Tabulated Summary of the FDG PET Literature

    Sanjiv S. Gambhir;Johannes Czernin;Judy Schwimmer;Daniel H. S. Silverman

  • Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

    Daniel H. S. Silverman;Gary W. Small;Carol Y. Chang;Carolyn S. Lu

  • Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

    George V Thomas;Chris Tran;Ingo K Mellinghoff;Derek S Welsbie

  • Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction

    Marcelo F. Di Carli;Michael Davidson;Roderick Little;Sandeep Khanna

  • Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

    Wolfgang P Fendler;Wolfgang P Fendler;Jeremie Calais;Matthias Eiber;Matthias Eiber;Robert R Flavell

  • LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

    David B. Shackelford;David B. Shackelford;Evan Abt;Laurie Gerken;Debbie S. Vasquez

  • Influence of age and hemodynamics on myocardial blood flow and flow reserve.

    J. Czernin;P. Müller;Sammy Chan;R. C. Brunken

  • A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

    Ralf H. Huebner;Kenneth C. Park;James E. Shepherd;Judy Schwimmer

  • Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice

    Barbara J. Fueger;Johannes Czernin;Isabel Hildebrandt;Chris Tran

  • Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG

    Wei Chen;Timothy Cloughesy;Nirav Kamdar;Nagichettiar Satyamurthy

  • Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study

    Wei Chen;Sibylle Delaloye;Daniel H.S. Silverman;Cheri Geist

  • 18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy

    Wei Chen;Daniel H S Silverman;Sibylle Delaloye;Johannes Czernin

  • Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.

    Johannes Czernin;Martin Allen-Auerbach;Heinrich R Schelbert

  • Positron emission tomography scanning: current and future applications.

    Johannes Czernin;Michael E. Phelps

  • 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.

    Jeremie Calais;Francesco Ceci;Francesco Ceci;Matthias Eiber;Matthias Eiber;Thomas A Hope

  • Relation Among Stenosis Severity, Myocardial Blood Flow, and Flow Reserve in Patients With Coronary Artery Disease

    Marcelo Di Carli;Johannes Czernin;Carl K. Hoh;Victor H. Gerbaudo

  • Molecular Mechanisms of Bone 18F-NaF Deposition

    Johannes Czernin;Nagichettiar Satyamurthy;Christiaan Schiepers

  • Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.

    Shahriar S Yaghoubi;Michael C Jensen;Nagichettiar Satyamurthy;Shradha Budhiraja

  • Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions

    Shanna K Kim;Martin Allen-Auerbach;Jonathan Goldin;Barbara J Fueger

  • EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).

    Clemens Kratochwil;Wolfgang Peter Fendler;Matthias Eiber;Richard Baum

Frequent Co-Authors

Michael E. Phelps
Michael E. Phelps University of California, Los Angeles
Ken Herrmann
Ken Herrmann German Cancer Research Center
Daniel H.S. Silverman
Daniel H.S. Silverman University of California, Los Angeles
Caius G. Radu
Caius G. Radu University of California, Los Angeles
Heinrich R. Schelbert
Heinrich R. Schelbert University of California, Los Angeles
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Robert E. Reiter
Robert E. Reiter University of California, Los Angeles
David Elashoff
David Elashoff University of California, Los Angeles
Sanjiv S. Gambhir
Sanjiv S. Gambhir Stanford University
Albert Lai
Albert Lai University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t have to follow a traditional path. Many students are now considering flexible alternatives through online degrees that expand healthcare career opportunities beyond medical school.

If your interests lean toward mental health, becoming a nurse practitioner is an in-demand path. You can fast-track your education with the fastest psych np program options, allowing you to begin your clinical career sooner.

For those interested in the business side of healthcare, there are many affordable healthcare administration degree online programs. Earning a management degree can open doors to roles in hospitals, clinics, and other healthcare organizations.

Looking to advance further? Investigate the mha degree cost to find budget-friendly Master’s options, or consider pursuing your doctorate through dnp online programs cheap to reach top leadership or clinical roles in medicine.

With these flexible pathways, you can tailor your healthcare career to your skills, interests, and timeframe—often with greater affordability and convenience.

Best Scientists Citing Johannes Czernin

Trending Scientists

Recently Published Articles